Quick Answer
Pasithea Therapeutics Corp. reported Net Income Loss of -$20.43 million for the year ending 2025.
- Pasithea Therapeutics Corp. showed a decrease of -46.9% in Net Income Loss from 2024 to 2025.
- This data is from Pasithea Therapeutics Corp.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Pasithea Therapeutics Corp.'s Net Income Loss has declined by 839.8%.
- Historical annual values: Fiscal year 2025: -$20.43 million | Fiscal year 2024: -$13.90 million | Fiscal year 2023: -$15.96 million | Fiscal year 2022: -$13.94 million | Fiscal year 2021: -$2.17 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: